Kazia Therapeutics (ADR) (KZIA)
Develops paxalisib and licensed oncology programs for treatment-resistant cancers.
$10.12
vs last close−0.80 (−7.37%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 224.68% | 3.64M ADS | |
|---|---|---|---|
| 41 holders · as of Jun 30, 2026 | |||
| Insiders | 0.10% | 1.6K ADS | |
| 1 holder · as of Mar 18, 2026 | |||
| Adds to | 224.78% | ||
1.62M ADS (1 ADS = 10 ordinary shares) as of Sep 9, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Jun 2022 annual report; nothing newer is on file here.
These groups come from separate filings that can overlap, so they add to 224.78%; nothing is left for Other.
13F, as of Jun 30, 2026
41 holders · 3.64M shares · 18 new positions · 27 increased · 5 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Boxer Capital Management, LLC | 560.0K | 34.57% | +560.0Knew | Aug 14, 2026 |
| Flputnam Investment Management Co | 415.0K | 25.62% | +272.5K | Aug 6, 2026 |
| Bleichroeder LP | 400.0K | 24.69% | 0 | Aug 13, 2026 |
| Ikarian Capital, LLC | 396.2K | 24.46% | +396.2Knew | Aug 14, 2026 |
| Dauntless Investment Group, LLC | 354.2K | 21.87% | +274.4K | Aug 13, 2026 |
| Stonepine Capital Management, LLC | 345.2K | 21.31% | 0 | Aug 17, 2026 |
| Point72 Asset Management, L.P. | 200.3K | 12.37% | +300 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | 110.8K | 6.84% | +110.8Knew | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Chernett Jorey | 18.50% | 2.11M | 13G | May 27, 2026 |
| Lynwood Capital Management Inc. | 5.40% | 13G | Jan 23, 2026 | |
| Ikarian Capital, LLC | 5.10% | 580.8K | 13G | Feb 17, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.